Sinemet (MSD) is a combined preparation each tablet of which contains levodopa 250 mg
and carbidopa 25 mg. It is used for the treatment of Parkinsonism. Levodopa is now …

Sinemet (MSD) is a combined preparation each tablet of which contains levodopa 250 mg
and carbidopa 25 mg. It is used for the treatment of Parkinsonism. Levodopa is now …

'Sinemet-Plus' contains 100 mg of levodopa and 25 mg of carbidopa.'Sinemet-Plus' provides
a low dose of levodopa together with sufficient carbidopa to inhibit effectively peripheral …

US5624960A - Orally administrable drugs for the treatment of central dopamine deficiency
conditions - Google Patents US5624960A - Orally administrable drugs for the treatment of …

BACKGROUND OF THE INVENTION This is a division of application Ser. No. 223,861? led
July 25, 1988, now US Pat. No. 4,832,957, which is a continuation-in-part of copending …

BACKGROUND OF THE INVENTION L-dopa alone or in combination with a peripheral de
carboxylase inhibitor is used for the treatment of Park inson's disease and is particulary …

WO1992012710A1 - Peroral applizierbare arzneiform zur behandlung zentraler
dopaminmangelzustände - Google Patents WO1992012710A1 - Peroral applizierbare arzneiform …

BACKGROUND OF THE INVENTION This invention is concerned with a controlled release
formulation for the simultaneous delivery of levodopa and carbidopa in the treatment of …

US20070042037A1 - Pharmaceutical composition containing levodopa and carbidopa -
Google Patents US20070042037A1 - Pharmaceutical composition containing levodopa and …

The present disclosure provides a method for the treatment of Parkinson's disease
comprising simultaneously or sequentially administering to a patient in need of treatment of …